Both groups showed a significant reduction in mean the Excitement Component of the PANSS score (PANSS‐EC) (mean reductions of –12.9 in patients treated with orally disintegrating olanzapine tablet and –13.6 in patients treated with other pharmacological treatment). 0000000016 00000 n
PRECAUTIONS: Before taking olanzapine, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies.This product may contain inactive ingredients, which can cause allergic reactions or other problems. Each orally disintegrating tablet contains olanzapine equivalent to 5 mg (16 μmol), 10 mg (32 μmol), 15 mg (48 μmol) or 20 mg (64 μmol). Symptoms and signs include anger, social withdrawal, vocal outbursts, fatigue, physical complaints, and thoughts of suicide. The data show that about one‐third of patients receiving treatment of schizophrenia are declared partially compliant, meaning they will either reduce the prescribed drug dose or fail to take the medication from time to time, and another one‐third do not follow prescription instructions at all [Consequences of nonadherence include nonremitting symptoms, relapse, or recurring or fluctuating adverse effects. IV�C.���$�5D0�p���Cs6n/d�2��p��!��E4"aa|:i&j� ��|o݄'�{_�\�|�='����9&��aq���O�B�C�bX�|�'wx�N2E�C����\guV4r[�MVl��� ��_L�"$� ��/�TI��b Research on adherence to interventions for mental disordersIncreased suicide attempt rate among patients interrupting use of atypical antipsychoticsCompliance in schizophrenia: Predictive factors, therapeutical considerations and research implicationsPrediction of homelessness within three months of discharge among inpatients with schizophreniaRelapse prevention and recovery in the treatment of schizophreniaA prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophreniaDeterminants of medication compliance in schizophrenia: Empirical and clinical findingsFactors influencing compliance in schizophrenia patientsNew antipsychotics, compliance, quality of life, and subjective tolerability–are patients better off?Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysisSwitching from depot antipsychotic drugs to olanzapine in patients with chronic schizophreniaDrug delivery products and the Zydis fast‐dissolving dosage formConsumer preference for orally disintegrating tablets over conventional forms of medication: Evolving methodology for medication intake in dysphagia [lecture]12th Annual Meeting of the Dysphagia Research Society Oct 2–4Compliance in psychiatry: results of a survey of depressed patients using orally disintegrating tabletRapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: A summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerabilityRapid onset of absorption with olanzapine orally disintegrating tabletsPharmacokinetics and bioequivalence of olanzapine rapidly‐disintegrating tablets [abstract no. The other one is the fact that patients were willing to sign inform consent that might suggest the inclusion of relatively “more compliant” patients as was originally suggested by the patients' baseline characteristics.In addition to noncompliant patients, all patients can benefit from orally disintegrating olanzapine. You may report side effects to FDA at 1-800-FDA-1088.Other drugs may affect Zyprexa Zydis, including prescription and over-the-counter medicines, Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Copyright 1996-2018 Cerner Multum, Inc.